The firm has made an additional investment in Nature Corporation to support its growth in the health and wellness sector.

Target Information

We are pleased to announce that we have made an additional investment in Nature Corporation. This strategic move is part of our ongoing commitment to support innovative companies in the health and wellness sector.

Nature Corporation is a pioneering company known for its commitment to creating sustainable and natural products that promote overall well-being. With a robust portfolio that emphasizes eco-friendliness and health benefits, the company has garnered significant attention in the market.

Industry Overview in Japan

The health and wellness industry in Japan has seen remarkable growth over the past few years, driven by a growing awareness of health issues and a ris

View Source

Similar Deals

Yoshio Uekusa MEDIROM MOTHER Labs Inc.

2025

Series A Healthcare Facilities & Services (NEC) Japan
Yasuhiro Hayami Mother Labs

2025

Series A Medical Software & Technology Services Japan
Not Specified Symbiobe株式会社

2024

Series A Biotechnology & Medical Research (NEC) Japan
Catalys Pacific and SR One Renalys Pharma, Inc.

2024

Series A Proprietary & Advanced Pharmaceuticals Japan

Our Company

invested in

Nature Corporation

in 2024

in a Series A deal

Disclosed details

Transaction Size: $102M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert